Related Experiment Videos
A case of tardive dyskinesia caused by metoclopramide
Abstract:
Abnormal involuntary movements appeared in the mouth, tongue, neck and abdomen of a 64-year-old male patient after he took metoclopramide for gastrointestinal disorder in a regimen of 30 mg per day for a total of about 260 days. The symptoms exacerbated to a maximum in a month. When the metoclopramide administration was discontinued, the abnormal movements gradually improved to a considerable extent. Attention to the possible induction of specific tardive dyskinesia is called for in the use of this drug.
Insights
Metoclopramide can cause tardive dyskinesia, a movement disorder affecting the mouth, tongue, neck, and abdomen. Symptoms improved after discontinuing the drug, highlighting the need for careful monitoring.
Area of Science:
- Neurology
- Pharmacology
Background:
- Metoclopramide is commonly prescribed for gastrointestinal disorders.
- Tardive dyskinesia is a potential side effect of certain medications.
Observation:
- A 64-year-old male developed abnormal involuntary movements after 260 days of metoclopramide use (30 mg/day).
- Symptoms affected the mouth, tongue, neck, and abdomen, worsening within a month.
Findings:
- Discontinuation of metoclopramide led to significant improvement in abnormal movements.
- The patient's condition suggests a drug-induced tardive dyskinesia.
Implications:
- Clinicians should be aware of the risk of tardive dyskinesia with metoclopramide.
- Careful patient monitoring is essential during metoclopramide treatment.
- Early recognition and drug cessation can mitigate symptoms.